Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Burkitt Lymphoma 9Vomiting 5Nausea 5Lymphoma, Mantle-Cell 4Hodgkin Disease 4Breast Neoplasms 4Neoplasms, Plasma Cell 3Lymphoma, Non-Hodgkin 3Leukemia, Biphenotypic, Acute 3Immunoglobulin Light-chain Amyloidosis 3Sarcoma 2Recurrence 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Hairy Cell 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1

Interventions

Cyclophosphamide 12Whole-Body Irradiation 10fludarabine phosphate 9Rituximab 9Peripheral Blood Stem Cell Transplantation 9Cyclosporine 9Mycophenolic Acid 7Filgrastim 7Etoposide 6Dexamethasone 6Busulfan 6Methotrexate 5Tacrolimus 4Carboplatin 4Bortezomib 4Vorinostat 3Thiotepa 3Radiotherapy 3Lenalidomide 3Irinotecan 3Cytarabine 3Calcium Dobesilate 3merphos 2liposomal amphotericin B 2laromustine 2ixabepilone 2entinostat 2Transplantation 2Therapeutics 2Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Intraocular Lymphoma × dexamethasone acetate × Clear all
NCT01722305 2019-07-22

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Mayo Clinic

Phase 1 Completed
29 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡